Literature DB >> 6228245

Acne conglobata responding to buserelin, a gonadotrophin-releasing hormone analogue.

J Waxman, M H Rustin, L Perry, J D Kirby.   

Abstract

A 65-year-old man who had had acne conglabata since early adult life was treated with buserelin for advanced prostatic cancer. Within 1 month of starting therapy, the inflammatory acne had completely resolved and this coincided with remission of the carcinoma. Gonadotrophin-releasing hormone analogues may be useful in the treatment of resistant acne.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6228245     DOI: 10.1111/j.1365-2133.1983.tb00550.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  A major advance in the treatment of severe acne.

Authors:  D H Jones
Journal:  J R Soc Med       Date:  1985       Impact factor: 5.344

Review 2.  Acne and psoriasis.

Authors:  G M Murphy; M W Greaves
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

Review 3.  Gonadotrophin-releasing hormone agonists. A guide to use and selection.

Authors:  M Filicori
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.